Literature DB >> 60886

Evaluation of hepatoma chemotherapy by alpha-fetoprotein determination.

Y Matsumoto, T Suzuki, H Ono, A Nakase, I Honjo.   

Abstract

Effects of chemotherapy on twenty-nine histologically proved and alpha-fetoprotein (AFP) -positive hepatomas were evaluated by changes in serum AFP levels according to the criteria of our previous report. By transfemoral local infusion of mitomycin C, six of eight patients showed more than 50 per cent decrease of AFP levels and regression of the tumor, and the others showed fair effects. By single shot infusion, 50 per cent decrease of serum AFP levels and tumor regression were noted only in three of thirteen patients, and chemotherapy by systemic infusion in eight patients was much less effective. As evaluated by AFP levels, histologically well or moderately differentiated hepatocellular carcinomas responded better to chemotherapy than poorly differentiated ones.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 60886     DOI: 10.1016/0002-9610(76)90385-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Palliative and adjunctive measures in rectal cancer.

Authors:  A Fritsch; W Seidl; C Walzel; K Moser; R Schiessel
Journal:  World J Surg       Date:  1982-09       Impact factor: 3.352

2.  Value of α-fetoprotein as an early biomarker for treatment response to sorafenib therapy in advanced hepatocellular carcinoma.

Authors:  Ana Isabel Plano Sánchez; Lucía Velasco Roces; Isabel Zapico García; Eva Lázaro López; Miguel Angel Calleja Hernandez; Maria Isabel Baena Parejo; Jaime Peña-Díaz
Journal:  Oncol Lett       Date:  2018-03-30       Impact factor: 2.967

3.  Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.

Authors:  Ian Chau; Joon Oh Park; Baek-Yeol Ryoo; Chia-Jui Yen; Ronnie Poon; Davide Pastorelli; Jean-Frédéric Blanc; Masatoshi Kudo; Tulio Pfiffer; Etsuro Hatano; Hyun Cheol Chung; Katerina Kopeckova; Jean-Marc Phelip; Giovanni Brandi; Shinichi Ohkawa; Chung-Pin Li; Takuji Okusaka; Yanzhi Hsu; Paolo B Abada; Andrew X Zhu
Journal:  Br J Cancer       Date:  2018-05-29       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.